Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial (Q44392807)
Jump to navigation
Jump to search
scientific article published on 13 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial |
scientific article published on 13 June 2013 |
Statements
1 reference
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial (English)
1 reference
Piero Ruggenenti
1 reference
Annalisa Perna
1 reference
Flavio Gaspari
1 reference
Roberto Trevisan
1 reference
Aneliya Parvanova
1 reference
Irene M van der Meer
1 reference
Ilian Iliev
1 reference
Daglutril in Diabetic Nephropathy Study Group
1 reference
13 June 2013
1 reference
1 reference
Identifiers
1 reference